Concord Biotech IPO opens: Can this Big Bull-backed pharma player create magic?
Subscribing to the IPO may suit investors looking for a long-term investment but those looking for blockbuster returns like Mankind Pharma should probably temper their expectations. Read on to find out why
Source: moneycontrol.com